TY  - GEN
AU  - Halamkova,J
AU  - Kiss,I
AU  - Pavlovsky,Z
AU  - Tomasek,J
AU  - Jarkovsky,J
AU  - Cech,Z
AU  - Tucek,S
AU  - Hanakova,L
AU  - Moulis,M
AU  - Zavrelova,J
AU  - Man,M
AU  - Benda,P
AU  - Robek,O
AU  - Kala,Z
AU  - Penka,M
TI  - Clinical significance of the plasminogen activator system in relation to grade of tumor and treatment response in colorectal carcinoma patients
SN  - 0028-2685
PY  - 2011///0920
KW  - Adenocarcinoma
KW  - metabolism
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Colectomy
KW  - Colorectal Neoplasms
KW  - Combined Modality Therapy
KW  - Female
KW  - Humans
KW  - Immunoenzyme Techniques
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Plasminogen Activator Inhibitor 1
KW  - Plasminogen Activator Inhibitor 2
KW  - Prospective Studies
KW  - Receptors, Urokinase Plasminogen Activator
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Urokinase-Type Plasminogen Activator
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.4149/neo_2011_05_377
ER  -